Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Suppression of vaccine immunity by inflammatory monocytes.

Mitchell LA, Henderson AJ, Dow SW.

J Immunol. 2012 Dec 15;189(12):5612-21. doi: 10.4049/jimmunol.1202151. Epub 2012 Nov 7.

2.

Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity.

Mitchell LA, Hansen RJ, Beaupre AJ, Gustafson DL, Dow SW.

Int Immunopharmacol. 2013 Feb;15(2):357-63. doi: 10.1016/j.intimp.2012.11.016. Epub 2012 Dec 13.

3.

Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.

Yamano T, Kaneda Y, Huang S, Hiramatsu SH, Hoon DS.

Mol Ther. 2006 Jan;13(1):194-202. Epub 2005 Aug 22.

4.

Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity.

Qin H, Cha SC, Neelapu SS, Lou Y, Wei J, Liu YJ, Kwak LW.

Blood. 2009 Nov 5;114(19):4142-9. doi: 10.1182/blood-2009-05-219683. Epub 2009 Sep 11.

5.

Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses.

Rose AH, Hoffmann FW, Hara JH, Urschitz J, Moisyadi S, Hoffmann PR, Bertino P.

Hum Vaccin Immunother. 2015;11(9):2305-11. doi: 10.1080/21645515.2015.1047567. Epub 2015 Jun 19.

6.

Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues.

Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, von Andrian UH.

J Exp Med. 2001 Nov 5;194(9):1361-73.

7.

Type I interferon modulates monocyte recruitment and maturation in chronic inflammation.

Lee PY, Li Y, Kumagai Y, Xu Y, Weinstein JS, Kellner ES, Nacionales DC, Butfiloski EJ, van Rooijen N, Akira S, Sobel ES, Satoh M, Reeves WH.

Am J Pathol. 2009 Nov;175(5):2023-33. doi: 10.2353/ajpath.2009.090328. Epub 2009 Oct 1.

8.
9.

Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes.

Katsuki S, Matoba T, Nakashiro S, Sato K, Koga J, Nakano K, Nakano Y, Egusa S, Sunagawa K, Egashira K.

Circulation. 2014 Feb 25;129(8):896-906. doi: 10.1161/CIRCULATIONAHA.113.002870. Epub 2013 Dec 4.

10.

Inducing Humoral Immune Responses Against Regulatory T Cells by Foxp3-Fc(IgG) Fusion Protein.

Niri NM, Hadjati J, Sadat M, Memarnejadian A, Aghasadeghi M, Akbarzadeh A, Zarghami N.

Monoclon Antib Immunodiagn Immunother. 2015 Dec;34(6):381-5. doi: 10.1089/mab.2015.0048.

PMID:
26683176
11.
12.
14.

Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation.

D'Mello C, Le T, Swain MG.

J Neurosci. 2009 Feb 18;29(7):2089-102. doi: 10.1523/JNEUROSCI.3567-08.2009.

15.

Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis.

Maus UA, Waelsch K, Kuziel WA, Delbeck T, Mack M, Blackwell TS, Christman JW, Schlöndorff D, Seeger W, Lohmeyer J.

J Immunol. 2003 Mar 15;170(6):3273-8.

16.

Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.

U'Ren L, Kedl R, Dow S.

Cancer Gene Ther. 2006 Nov;13(11):1033-44. Epub 2006 Jul 14.

PMID:
16841080
17.

Monocyte-derived dendritic cell recruitment and allergic T(H)2 responses after exposure to diesel particles are CCR2 dependent.

Provoost S, Maes T, Joos GF, Tournoy KG.

J Allergy Clin Immunol. 2012 Feb;129(2):483-91. doi: 10.1016/j.jaci.2011.07.051. Epub 2011 Sep 8.

PMID:
21906792
18.

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.

Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J.

J Immunol. 2005 May 15;174(10):6292-8.

19.

Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.

Takeda K, Dow SW, Miyahara N, Kodama T, Koya T, Taube C, Joetham A, Park JW, Dakhama A, Kedl RM, Gelfand EW.

J Immunol. 2009 Jul 1;183(1):181-90. doi: 10.4049/jimmunol.0803967.

20.

Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.

Bauer C, Sterzik A, Bauernfeind F, Duewell P, Conrad C, Kiefl R, Endres S, Eigler A, Schnurr M, Dauer M.

Cancer Immunol Immunother. 2014 Apr;63(4):321-33. doi: 10.1007/s00262-013-1510-y. Epub 2014 Jan 3.

PMID:
24384835

Supplemental Content

Support Center